Anti-aging effect of recombinant Morchella eximia immunomodulatory protein on Caenorhabditis elegans
A fungal immunomodulatory protein (FIP) (MeIMP) was discovered in edible mushroom Morchella eximia . Bioinformatics analysis demonstrated that MeIMP possesses cerato-platanin domains. Phylogenetic analysis positioned MeIMP within a distinct branch of the FIP family. The MeIMP gene was cloned and expressed in the Rosetta (DE3) strain. The anti-aging effect of recombinant MeIMP (rMeIMP) was evaluated by several indicators of Caenorhabditis elegans ( C. elegans ). The results indicated that rMeIMP significantly prolonged the lifespan of C. elegans , enhanced their motility ability, and diminished lipofuscin accumulation, while not affecting reproductive ability. Under UV, high temperature, and hydrogen peroxide stress, rMeIMP also significantly prolonged survival times of C. elegans . Additionally, rMeIMP extended the lifespan of C. elegans by scavenging ROS to mitigate the detrimental effects of oxidative stress. The establishment of a prokaryotic expression system for MeIMP and the assessment of rMeIMP function provided valuable insights for the further development and utilization of MeIMP. • Recombinant MeIMP was successfully cloned and expressed in the Rosetta (DE3) strain. • rMeIMP significantly extended the lifespan of Caenorhabditis elegans . • rMeIMP enhanced the stress resistance capacity of Caenorhabditis elegans .
Authors
- Mengxiang Gao (ORCID: https://orcid.org/0000-0002-7272-1304)
- Jinyan Li (ORCID: https://orcid.org/0000-0003-1833-7413)
- Li Li (ORCID: https://orcid.org/0000-0002-9164-5909)
- Jialan Zhang (ORCID: https://orcid.org/0000-0002-9176-4895)
- Tong Gu
Institutions
- Yangtze University (CN)
- Institute of Food Science and Technology (CN)
Publication Details
- Journal
- Journal of Functional Foods
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.jff.2025.106709
- Citations
- 1
- Primary Topic
- Genetics, Aging, and Longevity in Model Organisms
- Type
- article
- Field-Weighted Citation Impact
- 0.95